WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.

Piperacillin-Tazobactam Breakpoints for Pseudomonas aeruginosa, 1st Edition

View Sample Pages

CLSI MR15

Piperacillin-Tazobactam Breakpoints for Pseudomonas aeruginosa, 1st Edition

This CLSI rationale document is based on data compiled by the CLSI Working Group on Piperacillin-Tazobactam to reassess piperacillin-tazobactam breakpoints against Pseudomonas aeruginosa. 

This edition of the document was corrected in February 2024. Read the correction notices by accessing the link above, and learn more about our correction process here.

This document is available in electronic format only.

Member price:

List Price:
Log in/sign up to see price and add to cart

Details

Chairholder: Romney M. Humphries, PhD, D(ABMM), FIDSA; Pranita D. Tamma, MD, MHS

Date of Publication: January 2, 2024

Order Code PDF: CLSI MR15Ed1E
ISBN Number: 978-1-68440-212-0

Order Code Print: print not available

Edition: First

Pages: 12

CLSI uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our privacy policy.

Accept